Connect with us

COVID-19

Public Health Agency of Canada “not recommending an additional bivalent booster for the general population this spring”

Published

5 minute read

The federal and provincial governments will have to figure out what to do with millions of COVID-19 vaccine boosters now that it appears they’ll go unused.  On Friday, the Public Health Agency of Canada announced through it’s twitter feed that booster shots should now only be considered for Canadians “at high risk of severe illness”.
Those considered at high risk are those over 80 years old, people between 65 and 79 who haven’t contracted COVID-19 yet, residents living in long-term care homes or with other seniors with complex medical needs, and adults 18 and over who are moderately or severely immunocompromised.
The vast majority of Canadians have already been avoiding the booster shots.  Almost 80% of Canadians haven’t taken a booster in the last 6 months.
It’s also been about 6 months since the Public Health Agency of Canada has reported on the likelihood of becoming ill with COVID-19, being hospitalized or dying while vaccinated and boosted. The last report was made public back at the end of September.

 

Below is the statement on the Public Health Agency of Canada website from Friday, March 3:

OVERVIEW

  • On March 3, 2023, the Public Health Agency of Canada (PHAC) released guidance from the National Advisory Committee on Immunization (NACI) on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19. This guidance is based on current evidence, vaccine principles and NACI expert opinion.
  • NACI now recommends that: Starting in the spring of 2023, an additional booster dose may be offered 6 or more months from the last COVID-19 vaccine dose or infection to the following individuals who are at increased risk of severe illness from COVID-19: (Discretionary NACI recommendation)
    • Adults 80 years of age and older
    • Adults 65 to 79 years of age, particularly if they do not have a known history of SARS-CoV-2 infection
    • Adult residents of long-term care homes and other congregate living settings for seniors or those with complex medical care needs
    • Adults 18 years of age and older who are moderately to severely immunocompromised due to an underlying condition or treatment
  • Bivalent Omicron-targeting mRNA COVID-19 vaccines continue to be the preferred booster products.
  • Individuals who have not received previously recommended doses, including a primary series or fall 2022 booster dose, are recommended to receive them now. For more information, please refer to Guidance on COVID-19 vaccine booster doses: Initial considerations for 2023.

QUOTES

“Bivalent booster dose uptake is still relatively low among the populations at risk of severe disease, and we hope to see this improve. Older adults, particularly those over 80 years, consistently have the highest risk of severe disease, especially if they are unvaccinated. We have historically seen patterns of waning protection against severe disease by 6 months after the last dose, particularly in older adults without prior infection. Because of this, as a precautionary measure, NACI is recommending this spring that an additional bivalent booster dose may be offered after 6 months for those at highest risk of severe disease, including older adults and persons who are moderately to severely immunocompromised. There may be a broader program in fall of 2023, depending on COVID-19 epidemiology.”

– Dr. Shelley Deeks, NACI Chair

“It remains important to stay up to date with your COVID-19 vaccines, including recommended booster doses, given the continued circulation of SARS-CoV-2 virus variants in Canada and elsewhere. Booster doses help to build back protection against severe disease that wanes over time after COVID-19 vaccination or infections. Given the current COVID-19 epidemiology, including the relatively stable disease activity we have observed in recent months, and generally high levels of antibodies against COVID-19 from vaccines and/or infection among Canadians, NACI is currently not recommending an additional bivalent booster for the general population this spring. However, individuals at highest risk of getting severely ill from COVID-19, including older adults and individuals considered immunocompromised, may be offered a spring bivalent booster dose. Regardless of risk factors, I encourage anyone who has not yet received their primary series or their fall 2022 bivalent booster to get these vaccinations now to reduce their risk of severe outcomes of COVID-19, including hospitalization.”

– Dr. Theresa Tam, Chief Public Health Officer

 

After 15 years as a TV reporter with Global and CBC and as news director of RDTV in Red Deer, Duane set out on his own 2008 as a visual storyteller. During this period, he became fascinated with a burgeoning online world and how it could better serve local communities. This fascination led to Todayville, launched in 2016.

Follow Author

COVID-19

Trump DOJ seeks to quash Pfizer whistleblower’s lawsuit over COVID shots

Published on

From LifeSiteNews

By Calvin Freiburger

The Justice Department attorney did not mention the Trump FDA’s recent admission linking the COVID shots to at least 10 child deaths so far.

The Trump Department of Justice (DOJ) is attempting to dismiss a whistleblower case against Pfizer over its COVID-19 shots, even as the Trump Food & Drug Administration (FDA) is beginning to admit their culpability in children’ s deaths.

As previously covered by LifeSiteNews, in 2021 the BMJ published a report on insider information from a former regional director of the medical research company Ventavia, which Pfizer hired in 2020 to conduct research for the company’s mRNA-based COVID-19 shot.

The regional director, Brook Jackson, sent BMJ “dozens of internal company documents, photos, audio recordings, and emails,” which “revealed a host of poor clinical trial research practices occurring at Ventavia that could impact data integrity and patient safety […] We also discovered that, despite receiving a direct complaint about these problems over a year ago, the FDA did not inspect Ventavia’s trial sites.”

According to the report, Ventavia “falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial.” Overwhelmed by numerous problems with the trial data, Jackson filed an official complaint with the FDA.

Jackson was fired the same day, and Ventavia later claimed that Jackson did not work on the Pfizer COVID-19 shot trial; but Jackson produced documents proving she had been invited to the Pfizer trial team and given access codes to software relating to the trial. Jackson filed a lawsuit against Pfizer for violating the federal False Claims Act and other regulations in January 2021, which was sealed until February 2022. That case has been ongoing ever since.

Last August, U.S. District Judge Michael Truncale dismissed most of Jackson’s claims with prejudice, meaning they could not be refiled. Jackson challenged the decision, but the Trump DOJ has argued in court to uphold it, Just the News reports, with DOJ attorney Nicole Smith arguing that the case concerns preserving the government’s unfettered power to dismiss whistleblower cases.

The rationale echoes a recurring trend in DOJ strategy that Politico described in May as “preserving executive power and preventing courts from second-guessing agency decisions,” even in cases that involve “backing policies favored by Democrats.”

Jackson’s attorney Warner Mendenhall responded that the administration “really sort of made our case for us” in effectively admitting that DOJ is taking the Fair Claims Act’s “good cause” standard for state intervention to mean “mere desire to dismiss,” which infringes on his client’s “First Amendment right to access the courts, to vindicate what she learned.”

Mendenhall added that in a refiled case, Jackson “may be able to bring a very different case along the same lines, but with the additional information” to prove fraud, whereas rejection would send the message that “if fraud involves government complicity, don’t bother reporting it.”

“The truth is we do not know if we saved lives on balance,” admitted FDA Chief Medical Officer Vinay Prasad in a recent leaked email. “It is horrifying to consider that the U.S. vaccine regulation, including our actions, may have harmed more children than we saved. This requires humility and introspection.”

The COVID shots have been highly controversial ever since the first Trump administration’s Operation Warp Speed initiative prepared and released them in a fraction of the time any previous vaccine had ever been developed and tested. As LifeSiteNews has extensively covered, a large body of evidence has steadily accumulated over the past five years indicating that the COVID jabs failed to prevent transmission and, more importantly, carried severe risks of their own.

Ever since, many have intently watched and hotly debated what President Donald Trump would do about the situation upon his return to office. Though he never backed mandates like former President Joe Biden did, for years Trump refused to disavow the shots to the chagrin of his base, seeing Operation Warp Speed as one of his crowning achievements. At the same time, during his latest run he embraced the “Make America Healthy Again” movement and its suspicion of the medical establishment more broadly.

So far, Trump’s second administration has rolled back several recommendations for the shots but not yet pulled them from the market, despite hiring several vocal critics of the COVID establishment and putting the Department of Health & Human Services under the leadership of America’s most prominent anti-vaccine advocate, Robert F. Kennedy Jr. Most recently, the administration has settled on leaving the current jabs optional but not supporting work to develop successors.

In a July interview, FDA Commissioner Marty Makary asked for patience from those unsatisfied by the administration’s handling of the shots, insisting more time was needed for comprehensive trials to get more definitive data.

Continue Reading

COVID-19

University of Colorado will pay $10 million to staff, students for trying to force them to take COVID shots

Published on

From LifeSiteNews

By Calvin Freiburger

The University of Colorado Anschutz School of Medicine caused ‘life-altering damage’ to Catholics and other religious groups by denying them exemptions to its COVID shot mandate, and now the school must pay a hefty settlement.

The University of Colorado’s Anschutz School of Medicine must pay more than $10.3 million to 18 plaintiffs it attempted to force into taking COVID-19 shots despite religious objections, in a settlement announced by the religious liberty law firm the Thomas More Society.

As previously covered by LifeSiteNews, in April 2021, the University of Colorado (UC) announced its requirement that all staff and students receive COVID jabs, leaving specific policy details to individual campuses. On September 1, 2021, it enforced an updated policy stating that “religious exemption may be submitted based on a person’s religious belief whose teachings are opposed to all immunizations,” but required not only a written explanation why one’s “sincerely held religious belief, practice of observance prevents them” from taking the jabs, but also whether they “had an influenza or other vaccine in the past.”

On September 24, the policy was revised to stating that “religious accommodation may be granted based on an employee’s religious beliefs,” but “will not be granted if the accommodation would unduly burden the health and safety of other Individuals, patients, or the campus community.”

In practice, the school denied religious exemptions to Catholic, Buddhist, Eastern Orthodox, Evangelical, Protestant, and other applicants, most represented by Thomas More in a lawsuit contending that administrators “rejected any application for a religious exemption unless an applicant could convince the Administration that her religion ‘teaches (them) and all other adherents that immunizations are forbidden under all circumstances.’”

The UC system dropped the mandate in May 2023, but the harm had been done to those denied exemptions while it was in effect, including unpaid leave, eventual firing, being forced into remote work, and pay cuts.

In May 2024, a three-judge panel of the U.S. Tenth Circuit Court of Appeals rebuked the school for denying the accommodations. Writing for the majority, Judge Allison Eid found that a “government employer may not punish some employees, but not others, for the same activity, due only to differences in the employee’s religious beliefs.”

Now, Thomas More announces that year-long settlement negotiations have finally secured the aforementioned hefty settlement for their clients, covering damages, tuition costs, and attorney’s fees. It also ensured the UC will agree to allow and consider religious accommodation requests on an equal basis to medical exemption requests and abstain from probing the validity of applicants’ religious beliefs in the future.

“No amount of compensation or course-correction can make up for the life-altering damage Chancellor Elliman and Anschutz inflicted on the plaintiffs and so many others throughout this case, who felt forced to succumb to a manifestly irrational mandate,” declared senior Thomas More attorney Michael McHale. “At great, and sometimes career-ending, costs, our heroic clients fought for the First Amendment freedoms of all Americans who were put to the unconscionable choice of their livelihoods or their faith during what Justice Gorsuch has rightly declared one of ‘the greatest intrusion[s] on civil liberties in the peacetime history of this country.’ We are confident our clients’ long-overdue victory indeed confirms, despite the tyrannical efforts of many, that our shared constitutional right to religious liberty endures.”

On top of the numerous serious adverse medical events that have been linked to the COVID shots and their demonstrated ineffectiveness at reducing symptoms or transmission of the virus, many religious and pro-life Americans also object to the shots on moral grounds, due to the ethics of how they were developed.

Catholic World Report notes that similarly large sums have been won in other high-profile lawsuits against COVID shot mandates, including $10.3 million to more than 500 NorthShore University HealthSystem employees in 2022 and $12.7 million to a Catholic Michigander fired by Blue Cross Blue Shield in 2024.

Continue Reading

Trending

X